Lannett Company - News Releases http://lannett.investorroom.com/ Lannett Announces Fiscal 2018 Second-Quarter Financial Results; Reports Record Revenues, Strong Earnings http://lannett.investorroom.com/2018-02-07-Lannett-Announces-Fiscal-2018-Second-Quarter-Financial-Results-Reports-Record-Revenues-Strong-Earnings --Adjusted EPS Higher Than Expected; Full-Year Adjusted Profitability Expected to Improve-- Wed, 07 Feb 2018 16:15:00 -0500 http://lannett.investorroom.com/2018-02-07-Lannett-Announces-Fiscal-2018-Second-Quarter-Financial-Results-Reports-Record-Revenues-Strong-Earnings Lannett Voluntarily Pays Down $25 Million Of Term Loans http://lannett.investorroom.com/2018-02-07-Lannett-Voluntarily-Pays-Down-25-Million-Of-Term-Loans Wed, 07 Feb 2018 06:54:00 -0500 http://lannett.investorroom.com/2018-02-07-Lannett-Voluntarily-Pays-Down-25-Million-Of-Term-Loans Lannett Enters Into Consulting Agreement With Former CEO, Arthur Bedrosian http://lannett.investorroom.com/2018-02-01-Lannett-Enters-Into-Consulting-Agreement-With-Former-CEO-Arthur-Bedrosian Thu, 01 Feb 2018 06:54:00 -0500 http://lannett.investorroom.com/2018-02-01-Lannett-Enters-Into-Consulting-Agreement-With-Former-CEO-Arthur-Bedrosian Lannett To Report Fiscal 2018 Second-Quarter Financial Results, Host Conference Call On Wednesday, February 7 http://lannett.investorroom.com/2018-01-31-Lannett-To-Report-Fiscal-2018-Second-Quarter-Financial-Results-Host-Conference-Call-On-Wednesday-February-7 Wed, 31 Jan 2018 06:53:00 -0500 http://lannett.investorroom.com/2018-01-31-Lannett-To-Report-Fiscal-2018-Second-Quarter-Financial-Results-Host-Conference-Call-On-Wednesday-February-7 Lannett Names Timothy C. Crew To Board Of Directors http://lannett.investorroom.com/2018-01-18-Lannett-Names-Timothy-C-Crew-To-Board-Of-Directors Thu, 18 Jan 2018 06:53:00 -0500 http://lannett.investorroom.com/2018-01-18-Lannett-Names-Timothy-C-Crew-To-Board-Of-Directors Lannett Appoints Timothy C. Crew As CEO http://lannett.investorroom.com/2017-12-21-Lannett-Appoints-Timothy-C-Crew-As-CEO --Brings More Than 25 Years of Broad Pharmaceutical Industry Experience, Including Leadership Positions at Cipla, Teva, Dr. Reddy's and Bristol-Myers Squibb-- Thu, 21 Dec 2017 06:54:00 -0500 http://lannett.investorroom.com/2017-12-21-Lannett-Appoints-Timothy-C-Crew-As-CEO Lannett To Participate At Two Investment Conferences In December http://lannett.investorroom.com/2017-12-11-Lannett-To-Participate-At-Two-Investment-Conferences-In-December Mon, 11 Dec 2017 12:54:00 -0500 http://lannett.investorroom.com/2017-12-11-Lannett-To-Participate-At-Two-Investment-Conferences-In-December Lannett Announces FDA Acceptance Of 505(b)(2) New Drug Application For Cocaine Hydrochloride Topical Solution, A Proprietary Anesthetic Product http://lannett.investorroom.com/2017-12-01-Lannett-Announces-FDA-Acceptance-Of-505-b-2-New-Drug-Application-For-Cocaine-Hydrochloride-Topical-Solution-A-Proprietary-Anesthetic-Product Fri, 01 Dec 2017 06:53:00 -0500 http://lannett.investorroom.com/2017-12-01-Lannett-Announces-FDA-Acceptance-Of-505-b-2-New-Drug-Application-For-Cocaine-Hydrochloride-Topical-Solution-A-Proprietary-Anesthetic-Product Lannett Announces Agreement For Authorized Generic Version Of Toprol-XL® http://lannett.investorroom.com/2017-11-29-Lannett-Announces-Agreement-For-Authorized-Generic-Version-Of-Toprol-XL-R Wed, 29 Nov 2017 16:47:00 -0500 http://lannett.investorroom.com/2017-11-29-Lannett-Announces-Agreement-For-Authorized-Generic-Version-Of-Toprol-XL-R Lannett To Present At The Jefferies 2017 London Healthcare Conference On November 15 http://lannett.investorroom.com/2017-11-09-Lannett-To-Present-At-The-Jefferies-2017-London-Healthcare-Conference-On-November-15 Thu, 09 Nov 2017 06:56:00 -0500 http://lannett.investorroom.com/2017-11-09-Lannett-To-Present-At-The-Jefferies-2017-London-Healthcare-Conference-On-November-15